| Ryan Westbroek, FNP | |
|
475 40th St Ste 111, Ogden, UT 84403-1856 | |
| (801) 515-7997 | |
| (385) 333-7413 |
| Full Name | Ryan Westbroek |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 475 40th St Ste 111, Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144608050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 287581-4408 (Utah) | Secondary |
| 363L00000X | Nurse Practitioner | 287581-4405 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Symbii Home Health | West valley city, UT | Home health agency |
| Nell J Redfield Memorial Hospital | Malad, ID | Hospital |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Entity Name | Livewell Chiropractic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730335225 PECOS PAC ID: 9830121698 Enrollment ID: O20050901000466 |
News Archive
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.
The organisation of political power within and between nations and citizens fails to protect the public's health, according to the findings of a new Commission from The Lancet and the University of Oslo, published today [Tuesday 11 February].
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
› Verified 5 days ago
| Entity Name | Upri Murray |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497014096 PECOS PAC ID: 7214189760 Enrollment ID: O20121206000555 |
News Archive
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.
The organisation of political power within and between nations and citizens fails to protect the public's health, according to the findings of a new Commission from The Lancet and the University of Oslo, published today [Tuesday 11 February].
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
› Verified 5 days ago
| Entity Name | Brookstar Knee Clinic Ii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447607122 PECOS PAC ID: 1850680620 Enrollment ID: O20160518000271 |
News Archive
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.
The organisation of political power within and between nations and citizens fails to protect the public's health, according to the findings of a new Commission from The Lancet and the University of Oslo, published today [Tuesday 11 February].
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
› Verified 5 days ago
| Entity Name | Ryan Westbroek Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609538552 PECOS PAC ID: 3577952811 Enrollment ID: O20211108002243 |
News Archive
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.
The organisation of political power within and between nations and citizens fails to protect the public's health, according to the findings of a new Commission from The Lancet and the University of Oslo, published today [Tuesday 11 February].
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
› Verified 5 days ago
| Entity Name | Westbroek Family Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831841535 PECOS PAC ID: 0446642581 Enrollment ID: O20220121000867 |
News Archive
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.
The organisation of political power within and between nations and citizens fails to protect the public's health, according to the findings of a new Commission from The Lancet and the University of Oslo, published today [Tuesday 11 February].
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Westbroek, FNP 4126 S 5000 W, West Haven, UT 84401-9403 Ph: (801) 515-7997 | Ryan Westbroek, FNP 475 40th St Ste 111, Ogden, UT 84403-1856 Ph: (801) 515-7997 |
News Archive
The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.
Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.
The organisation of political power within and between nations and citizens fails to protect the public's health, according to the findings of a new Commission from The Lancet and the University of Oslo, published today [Tuesday 11 February].
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
› Verified 5 days ago
Trisha B Sears, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-866-3714 | |
Allyx Bowthorpe, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 434 E 5350 S Ste D, Ogden, UT 84405 Phone: 801-827-9100 Fax: 801-827-9110 | |
Justin Robert Haslam, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5740 Crestwood Dr, Ogden, UT 84405 Phone: 801-479-7771 Fax: 801-479-7795 | |
Carrie Hanni, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4403 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-7900 Fax: 801-387-7910 | |
Maline Johanna Cropper, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1068 Harrop St, Ogden, UT 84404 Phone: 435-760-5797 | |
Mrs. Victoria Dawn Olvera, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-2702 | |
Natalie Angelica Solis, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd Ste 1885, Ogden, UT 84403 Phone: 801-387-4870 |